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Abstract: Aqueous solubility is an important factor influencing several aspects 
of the pharmacokinetic profile of a drug. Numerous publications present dif-
ferent methodologies for the development of reliable computational models for 
the prediction of solubility from structure. The quality of such models can be 
significantly affected by the accuracy of the employed experimental solubility 
data. In this work, the importance of the accuracy of the experimental solubility 
data used for model training was investigated. Three data sets were used as 
training sets – data set 1, containing solubility data collected from various lite-
rature sources using a few criteria (n = 319), data set 2, created by substituting 
28 values from data set 1 with uniformly determined experimental data from 
one laboratory (n = 319), and data set 3, created by including 56 additional 
components, for which the solubility was also determined under uniform con-
ditions in the same laboratory, in the data set 2 (n = 375). The selection of the 
most significant descriptors was performed by the heuristic method, using one- 
-parameter and multi-parameter analysis. The correlations between the most 
significant descriptors and solubility were established using multi-linear regres-
sion analysis (MLR) for all three investigated data sets. Notable differences 
were observed between the equations corresponding to different data sets, sug-
gesting that models updated with new experimental data need to be additionally 
optimized. It was successfully shown that the inclusion of uniform experimen-
tal data consistently leads to an improvement in the correlation coefficients. 
These findings contribute to an emerging consensus that improving the reliabi-
lity of solubility prediction requires the inclusion of many diverse compounds 
for which solubility was measured under standardized conditions in the data set. 
Keywords: aqueous solubility prediction; experimental data; model training; 
heuristic method. 
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INTRODUCTION 
The solubility of drugs and drug-like compounds has been the subject of ex-
tensive studies aimed at finding a way to predict solubility from molecular struc-
ture. The aqueous solubility of a drug is an important factor that influences its 
absorption by, distribution in and elimination from the body.1 Since poor phar-
macokinetics is one of the major causes for late stage drug development failures,2 
it is clear that properties such as solubility need to be considered very early in the 
drug discovery process. Therefore, a reliable tool for the prediction of solubility 
from structure alone would be of great importance to help in the elimination of 
unsuitable candidates and reduction of overall development attrition rates. 
A considerable number of in silico models for the prediction of solubility 
have been proposed over the past decade.3–22 These utilize an ever-growing va-
riety of approaches that differ in the way structure is represented, in the nature of 
the descriptors or properties that are derived from molecular structure and in the 
regression methods used. The sheer volume of publications on novel methods for 
the prediction of solubility seems to indicate that none of the existing models is 
fully satisfactory.23 Consistent with this, very few of the proposed models for 
prediction of solubility have found practical implications in the drug discovery 
process, probably due to low prediction reliability. Whilst most of the published 
models perform satisfactorily with the test sets used for their validation, their per-
formance with more diverse data plummet considerably.24 
While significant progress has been made in developing new modelling tech-
niques, there is, nevertheless, an emerging consensus that moving forward will 
require focusing on altogether different issues affecting the performance of exist-
ing models. Most of the recent reviews on solubility prediction indicate that solu-
bility modelling efforts have suffered from some basic faults, such as training 
sets that are not drug-like, unknown or high experimental error, lack of structural 
diversity, incorrect tautomers or structures, neglect of ionization, no considera-
tion of salt and/or common ion issues, avoidance of crystal packing effects and 
range of solubility data that is not pharmaceutically relevant.25  
One of the issues is that the design of a good quality training set is some-
thing often overlooked.26 It is worth noting that any model is only as good as the 
data used for its generation. A training set codifies the relationship between the 
relevant property and chemical structure; therefore, the applicability domain as 
well as model reliability will depend heavily upon the choice of the training set. 
The most limiting factor in the choice of a proper training set is the accuracy of 
the experimental solubility data. Katritzky et al. demonstrated that the average 
standard deviation for solubility measurements originating from different sources 
is as high as 0.6log S units.27 Occasionally, the solubility values reported for one 
compound may differ by 2–3 log units; this large difference may originate from 
different experimental protocols. There are differences in sample concentration, 
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co-solvent presence, co-solvent concentration, incubation times, thermodynamic 
methods, kinetic methods, etc.28 In addition, inclusion of values that were not 
distinctly reported, such as those for intrinsic solubility, and other unintentional 
errors all contribute significantly to the overall experimental error that can plague 
a data set.29,30 In a recent work by Taskinen and Norinder, in which over 30 mo-
dels from the literature were reviewed, it was concluded that improving the accu-
racy and applicability will “require more consideration of the consistency of the 
experimental solubility data and the training set composition”.24 Other authors 
also stressed that further development will require large, diverse sets of high-qua-
lity, uniformly determined experimental data.30,31 
Despite the importance of this issue, there are very few published works 
dealing primarily with proposing carefully designed training sets. In one aspect 
this is understandable – consistent solubility data are not widely available and de-
termining them for a “QSPR-significant” number of compounds would be a time- 
-consuming, laborious and expensive endeavour. On the other hand, addressing 
the issue of a more selective collection of data from the literature is feasible. One 
such example is the data set proposed by Rytting et al., who set out clear criteria 
for the inclusion of experimental data.32 
Increasing interest in the importance of high-quality experimental data for 
modelling purposes was perhaps best exemplified in a recent paper by Llinas et 
al., in which researchers where challenged to develop a model based on 100 re-
liable solubility measurements and to use it to predict the solubility of 32 additio-
nal molecules provided.33 As the authors remarked, the findings of the challenge 
provided an overall perspective as to the current ability to estimate aqueous solu-
bility.34 
Based on the importance of this issue, the aim of this study was to investi-
gate whether the implementation of solubility data obtained under standardized 
experimental conditions can make a significant contribution to the process of es-




The set of 322 structurally diverse “drug-like” molecules proposed by Rytting et al.32 
served as the basis for the first set used in this study (data set 1). The solubility data originated 
from various literature sources and were collected following several criteria: (i) the given 
compound is a drug or drug-like molecule, solid at room temperature; (ii) the reported value is 
that of the intrinsic solubility at around 25 °C; (iii) for solubility measurement, the equilibrium 
must have been achieved over time, excess solid must be present at the end of testing and 
acceptable analytical methods must have been used for quantification. Due to geometrical 
optimisation issues, three molecules were excluded from the Rytting set; hence, data set 1 
consisted of 319 compounds. For the investigation of the implementation of experimental 
solubility data obtained under the uniform experimental conditions, the Sirius data set,35 
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consisting of 84 diverse drug molecules for which the solubility was determined using the 
Sirius CheqSol technique,36 was used. This potentiometric method for the measurement of in-
trinsic solubility is very accurate and allows for rapid equilibration of the experiment and col-
lection of the precipitate during the experiment for characterization.37 
Data set 2 was created by substituting 28 solubility values from data set 1 with those 
from the Sirius data set. Data set 3 was created by adding the remaining 56 molecules from 
the Sirius data set to data set 2 (Table I). The Table with structures of all components included 
in the Sirius data set can be obtained on request.35 
Table I. Data sets composition 
Data set Solubility values of compounds 
1 319 from ref. 32 
2 291 from ref. 32 and 28 from ref. 35 
3 291 from ref. 32 and 84 from ref. 35 
Structure optimisation and descriptor calculation 
All structures were constructed using Spartan software.38 Geometry optimisation was 
performed by the AM1 semi-empirical method implemented in the Spartan software. Calcu-
lation of descriptors was performed using the Codessa programme (comprehensive descriptors 
for structural and statistical analysis).39 A total of 728 descriptors were calculated and divided 
into five groups: constitutional, topological, geometrical, electrostatic and quantum-chemical. 
Correlation analysis 
The heuristic method implemented in the Codessa software was used for the selection of 
the most significant descriptors for the prediction of solubility. The most significant des-
criptors were selected in each group of descriptors using the heuristic method. Heuristic 5-pa-
rameter analysis was also used for selection of the five most significant descriptors among all 
descriptors calculated, which were then used for establishing a QSPR (quantitative structure– 
–property relationship) equation for each of the sets using the multiple linear regression (MLR) 
method. Prior to this, descriptor intercorrelation analysis was performed, so that no two des-
criptors appearing in the final equations have an intercorrelation coefficient larger than 0.5. 
RESULTS AND DISCUSSION 
The potential limit of the accuracy of experimental data on the predictability 
of solubility models should be addressed before turning to the purely computa-
tional methods, therefore the Sirius data set was used to investigate the extent to 
which the implementation of solubility data measured under the same standard-
dized method may influence the quality of the potential model training. The cre-
ation of data sets 1, 2 and 3 are described in the Experimental section. 
The heuristic method was applied for the selection of the most significant 
descriptors for the prediction of solubility to all three data sets. The most signi-
ficant descriptors for all three sets from each of the groups of descriptors ob-
tained by the heuristic method are presented in Table II. The most highly corre-
lated descriptor in all data sets was the partition coefficient (log P). Most of the 
selected electrostatic and quantum-chemical descriptors are derived from mole-
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cular surface areas (H-donor/acceptor surface areas) and relative electrostatic 
charges. This would indicate that the descriptors selected using the heuristic me-
thod proved to be related to the solvation mechanism of the molecules. 
Table II. The most significant descriptors among the five groups of descriptors, selected using 
the heuristic method 
Descriptora Data set 1 Data set 2 Data set 3 R² F R² F R² F 
Constitutional descriptors 
log P 0.5013 318.67 0.5337 362.77 0.5479 451.95 
NBR 0.3848 198.28 0.4116 221.73 0.4390 291.88 
RC 0.3587 177.33 0.3562 175.41 0.3289 182.81 
RBR 0.3133 144.65 0.3184 148.09 0.2978 158.16 
NC 0.3013 136.71 0.3294 155.70 0.3639 213.34 
NR 0.2651 114.34 0.2675 115.74 0.2765 142.53 
NAB 0.1885 73.63 0.2062 82.36 0.2686 136.97 
RN 0.1526 57.08 0.1570 59.05 – – 
GIall 0.1351 49.53 0.1479 55.04 0.2051 96.23 
MW 0.1283 46.65 0.1409 51.97 0.1962 91.05 
Topological descriptors 
0ABIC 0.2833 125.31 0.2943 132.19 0.2526 126.06 
0ACIC 0.2478 104.41 0.2661 114.94 0.2640 133.81 
1ACIC 0.2196 89.22 0.2339 96.76 – – 
1ABIC 0.2072 82.83 0.2147 86.68 – – 
2ACIC 0.1949 76.73 0.2089 83.72 – – 
3Randic 0.1926 75.62 0.2038 81.12 0.2446 120.76 
2CIC 0.1895 74.14 0.2224 90.68 0.2254 108.54 
1K&H 0.1884 73.59 0.2061 82.31 0.2576 129.40 
1Randic 0.1829 70.96 0.2023 80.39 0.2580 129.72 
2Randic – – 0.1938 76.19 0.2426 119.49 
0K&H – – – – 0.2327 113.13 
2K&H – – – – 0.2199 105.16 
Geometrical descriptors 
MSA 0.2312 95.31 0.2565 109.36 0.3125 169.57 
XY Shadow 0.2259 92.50 0.2495 105.38 0.2978 158.17 
IC 0.2176 88.19 0.2289 94.11 0.2550 127.69 
IB 0.1778 68.55 0.1868 72.80 0.2142 101.66 
MV 0.1613 60.99 0.1829 70.95 0.2378 116.35 
IA 0.1407 51.92 0.1500 55.93 0.1719 81.36 
ZX Shadow  32.46 0.1104 39.34 0.1685 75.56 
Electrostatic descriptors 
eFPSA-3 0.2603 111.56 0.2676 115.80 0.2759 142.10 
edHDSA-1/TMSA 0.2590 110.81 0.2678 115.96 0.2649 134.42 
edHDSA-2/TMSA 0.2555 108.82 0.2621 112.62 0.2554 127.93 
eHASA-2/TMSA 0.2282 93.74 0.2401 100.17 0.2454 121.31 
eHACA-2/TMSA 0.2189 88.82 0.2279 93.56 0.2333 113.48 
edHDSA-2/SQRT 0.2001 79.32 0.2037 81.09 – – 
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TABLE II. Continued 
Descriptora Data set 1 Data set 2 Data set 3 R² F R² F R² F 
Electrostatic descriptors 
edHDCA-1/TMSA 0.1984 78.48 0.2072 82.86 0.2091 98.60 
edHDCA-2/TMSA 0.1979 79.20 0.2040 81.22 0.2040 95.57 
eHASA-2/SQRT 0.1935 76.06 0.2035 81.01 – – 
eHASA-1/TMSA 0.1905 74.59 0.2026 80.54 0.2164 103.01 
ewWNSA-1 – – – – 0.2497 124.17 
eTMSA – – – – 0.2437 120.18 
Quantum-chemical descriptors 
ALFA-pol 0.2657 114.70 0.2873 127.79 0.3458 197.12 
qdHDSA-1/TMSA 0.2579 110.18 0.2673 115.67 0.2642 133.95 
qdHDSA-2/TMSA 0.2574 109.85 0.2645 113.99 0.2579 129.64 
qHASA-2/TMSA 0.2282 93.74 0.2401 100.17 0.2454 121.31 
qRNCG 0.2281 93.69 0.2393 99.72 0.2433 119.23 
PMIC 0.2176 88.19 0.2289 94.11 0.2550 127.31 
qdHDSA-2/SQRT 0.2005 79.52 0.2047 81.60 – – 
qHASA-2/SQRT 0.1935 76.06 0.2035 81.01 – – 
qHASA-1/TMSA 0.1905 74.59 0.2026 80.54 – – 
PMIC/# 0.1892 73.99 – – – – 
qTMSA – – – – 0.2437 120.16 
Etot2-c ex – – – – 0.2385 116.80 
qwWNSA-1 – – – – 0.2274 109.80 
aSymbols of descriptors used; constitutional: NBR – number of benzene rings, NC – number of C atoms, RBR – re-
lative number of benzene rings, RC – relative number of C atoms, RN – relative number of N atoms, NR – num-
ber of rings, NAB – number of aromatic bonds, GIall – gravitational index (all bonds), MW – molecular weight; 
topological: 0ACIC – average complementary information content (order 0), 1ACIC – average complementary 
information content (order 1), 2ACIC – average complementary information content (order 2), 0ABIC – average 
bonding information content (order 0), 1ABIC – average bonding information content (order 1), 2CIC – comple-
mentary information content (order 2), 1Randic – Randic index (order 1), 2Randic – Randic index (order 2), 
3Randic – Randic index (order 3), 0K&H – Kier & Hall index (order 0), 1K&H – Kier & Hall index (order 1), 
2K&H – Kier & Hall index (order 2); geometrical: XY Shadow – area of the shadow of the molecule projected 
on a plane defined by X and Y axes, ZX Shadow - area of the shadow of the molecule projected on a plane 
defined by Z and X axes, MSA – molecular surface area, MV – molecular volume, IA – moment of inertia A, IB 
– moment of inertia B, IC – moment of inertia C; electrostatic (Zefirov’s PC): eFPSA-3 – FPSA-3 fractional 
PPSA (PPSA-3/TMSA), edHDSA-1/TMSA – HA dependent HDSA-1/TMSA, edHDSA-2/TMSA – HA dependent 
HDSA-2/TMSA, edHDSA-2/SQRT – HA dependent HDSA-2/SQRT(TMSA), edHDCA-1/TMSA – HA dependent 
HDCA-1/TMSA, edHDCA-2/TMSA – HA dependent HDCA-2/TMSA, eHASA-1/TMSA – HASA-1/TMSA, 
eHASA-2/TMSA – HASA-2/TMSA, eHASA-2/SQRT – HASA-2/SQRT(TMSA); eHACA-2/TMSA – HACA-
2/TMSA, eTMSA – TMSA total molecular surface area, ewWNSA-1 – WNSA-1 weighted PNSA 
(PNSA1*TMSA/1000); quantum-chemical: ALFA-pol – ALFA polarizability (DIP), qdHDSA-1/TMSA – HA 
dependent HDSA-1/TMSA [Semi-MO PC], qdHDSA-2/TMSA – HA dependent HDSA-2/TMSA (semi-MO 
PC), qdHDSA-2/SQRT – HA dependent HDSA-2/SQRT(TMSA) (semi-MO PC), qHASA-1/TMSA – HASA-
1/TMSA (semi-MO PC), qHASA-2/TMSA – HASA-2/TMSA (semi-MO PC), qHASA-2/SQRT – HASA-
2/SQRT(TMSA) (semi-MO PC), PMIC – principal moment of inertia C, PMIC/# – principal moment of inertia 
C/# of atoms, qRNCG – RNCG relative negative charge (QMNEG/QTMINUS) (semi-MO PC), Etot2-c ex – total 
molecular 2-center exchange energy, qTMSA – TMSA total molecular surface area (semi-MO PC).  
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Comparing data sets 1 and 2, which differ only in the solubility values of 28 
compounds, the order of the most significant descriptors selected by the heuristic 
method in the one-parameter correlation among each of the five groups of des-
criptors remained relatively unchanged. However, there was an increase in the 
correlation coefficient in all the descriptors involved. Comparing data sets 1 and 
3, the order of the descriptors was slightly changed. Although the correlations of 
the individual descriptors decreased in a small number of instances, there was an 
overall improvement of the correlation in all descriptor groups. This would sug-
gest that if no additional components are included in the set, with just the experi-
mental data being altered, individual descriptors could retain their respective ca-
pacities for describing the correlation between solubility and structure. This does 
not hold true, however, when establishing a multi-parameter correlation, as is 
later demonstrated. 
Inclusion of additional components in data set 3 increased the diversity of 
the set. This can result in a change of relative importance of different molecular 
properties governing solubility (within a set), which in turn affects the signi-
ficance of selected molecular descriptors. In the present case, this was reflected 
in the reordering of closely related descriptors among each group of descriptors. 
The present observations showed that changing the experimental data in 
multi-parameter correlations tended to have even a greater impact. A five-para-
meter heuristic correlation analysis and subsequent MLR yielded the following 
QSPR equations for data sets 1, 2 and 3, respectively: 
log S = –0.63647log P – 0.01454qHBCA + 24.65157IC + 
 + 0.0107612AIC – 19.7268RNR, n = 319, R2 = 0.6616 (1) 
 log S = –0.42352log P + 0.559774Etot2-c ex/# – 0.00756qDPSA-3 + 
 + 9.912633qRNCG + 0.197134 min(#HA, #HD), n = 319, R2 = 0.6689 (2) 
 log S = – 0.60863log P – 0.04033NAB – 14.2527RNR – 
 0.01145qDPSA-3 + 2.020366eRNCG, n = 375, R2 = 0.7045 (3) 
where: log P – partition coefficient; 
qHBCA – HBCA H-bonding charged surface area (semi-MO PC); 
IC – moment of inertia C; 
2AIC – average information content (order 2); 
RNR – relative number of rings; 
Etot2-c ex/# – total molecular 2-center exchange energy/# of atoms; 
qDPSA-3 – DPSA-3 difference in CPSAs (PPSA3-PNSA3) (semi-MO PC); 
qRNCG – RNCG relative negative charge (QMNEG/QTMINUS) (semi-MO PC); 
min(#HA, #HD )- minimum number of H-acceptors/donors; 
NAB – number of aromatic bonds; 
RNR – relative number of rings; 
qDPSA-3– DPSA-3 difference in CPSAs (PPSA3-PNSA3) (semi-MO PC); 
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eRNCG - RNCG Relative negative charge (QMNEG/QTMINUS). 
The plots of the experimental vs. the predicted solubility values using these 
three equations for the three training sets are shown in Figs. 1–3. 
 
Fig. 1. The correlation between the experimental and predicted log S values 
for data set 1 (n = 319, R2 = 0.6616). 
Equation (1), derived from data set 1 (n = 319), has the smallest correlation 
coefficient of the three (R2 = 0.6616, RMSE = 0.9641). In comparison, Eq. (2) 
shows a somewhat improved performance, with a slightly better correlation coef-
ficient and a remarkable reduction in the root mean squared error (n = 319, R2 = 
= 0.6689, RMSE = 0.8623). Equation (3), derived from the supplemented set (n = 
= 375), has the best correlation coefficient and a slightly reduced RMSE, com-
pared to Eq. (1) (R2 = 0.7045, RMSE = 0.9382). Introduction of uniform ex-
perimental data consistently leads to an increase in the correlation coefficient. 
This can be attributed to both the correction of outliers and the improvement of 
overall data consistency. 
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Fig. 2. The correlation between the experimental and predicted log S values 
for data set 2 (n = 319, R2 = 0.6689). 
Moving from single to multi-parameter correlations, the difference in selec-
tion of the most significant descriptors using the three data sets became more 
evident. The equation corresponding to data set 1 is composed of 2 constitutional, 
1 geometrical, 1 topological and 1 quantum-chemical descriptor. On the other 
hand, Eq. (2) was established using 1 constitutional and 4 quantum-chemical des-
criptors, which together account for several aspects of the solvation process, es-
pecially polar interactions and the possibility of H-bond formation. Thus, while 
the R2 values for Eqs. (1) and (2) are similar, the interpretability of these equa-
tions is significantly affected by the changes in the solubility values of the data 
set. On average, these values for the 28 substitutions made between data set 1 and 
2 (Table III) differ by 0.57log S. This is largely consistent with observations 
made by Katritzky et al.27 Differences in excess of 1.5log S are also present in 
some instances, e.g., phenylbutazone, propranolol, sulfamerazine and notably ter-
fenadine, for which the values differ by 3log S. Such large-scale differences can 
clearly affect the selection of the most significant descriptors. Data Set 3 is struc-
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turally more diverse than the previous two, thus the corresponding Eq. (3) also 
features a different combination of descriptors. It is composed of 3 constitutional 
and 2 quantum-chemical descriptors. These descriptors encompass molecular pro-
perties that relate to hydrophobicity as well as those that facilitate solvation. In 
summary, both the structural diversity of the training set and the standardized ex-
perimental solubility data included in the training significantly influence not just 
the statistical performance but also the interpretability of a prospective model. 
 
Fig. 3. The correlation between the experimental and predicted log S values 
for data set 3 (n = 375, R2 = 0.7045). 
TABLE III. Rytting solubility data used in data set 1, substituted with Sirius solubility data 
used in data Set 2 (No. of compounds: 28) 
Compound 
log S 
Rytting (data set 1) Sirius (data set 2) 
Amitriptyline –4.4560 –4.3900 
Benzocaine –2.6160 –2.2300 
Benzoic acid –1.5550 –1.6100 
Chlorzoxazone –2.8310 –2.6100 
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TABLE III. Continued 
Compound 
log S 
Rytting (data set 1) Sirius (data set 2) 
Diclofenac –5.0970 –5.4500 
Flufenamic acid –4.6230 –5.3500 
Flurbiprofen –3.7400 –4.1100 
Folic acid –5.4410 –5.3100 
Haloperidol –4.4290 –5.4700 
Hydrochlorothiazide –2.6890 –2.6800 
Ibuprofen –3.4200 –3.6100 
Lidocaine –1.7680 –1.8500 
Metoclopramide –3.1760 –3.5900 
Nadolol –1.0080 –1.5700 
Naproxen –4.1550 –4.1400 
Nitrofurantoin –3.4770 –3.3300 
Norfloxacin –3.0570 –2.7500 
Paracetamol –1.0740 –1.0000 
Phenobarbital –2.3660 –2.2800 
Phenylbutazone –2.6440 –4.3900 
Prochlorperazine –4.3980 –4.8700 
Promethazine –4.2600 –4.1900 
Propranolol –0.7140 –3.5000 
Quinine –2.7900 –2.8100 
Sulfamerazine –1.2180 –3.1000 
Sulfathiazole –2.8050 –2.7000 
Sulindac –5.0000 –4.5200 
Terfenadine –4.6740 –7.7400 
CONCLUSIONS 
Solubility is a difficult property to predict, and one reason for this is the ab-
sence of a high-quality data set of reliable and reproducible solubility measure-
ments. Hopefully, by measuring many compounds under standardized conditions, 
current predictive models can be improved. In this work, an attempt was made to 
demonstrate the importance of implementing such data to improve the confidence 
of the training of the models. 
It was successfully shown that the usage of uniform experimental data can 
significantly improve the correlation in the training set. The results also showed 
that updating existing data sets with such data leads to changes in the selection of 
the most significant descriptor, which would require the given model to be addi-
tionally optimized. Continuously updated models would be a valuable tool for pre-
liminary solubility screening and could be developed alongside solubility measu-
rement devices as added value software. 
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Farmaceutski fakultet, Univerzitet u Beogradu, Vojvode Stepe 450, 11000 Beograd i 
2Biotechnical 
Faculty, University of Bihać, Kulina Bana 2, 77000 Bihać, Bosnia and Herzegovina 
Растворљивост лека у води је значајан фактор који утиче на више аспеката његовог 
фармакокинетичког профила. Бројне публикације презентују различите методологије за раз-
вој поузданих компјутерских модела за предвиђање растворљивости на основу структуре је-
дињења. Квалитет модела за предвиђање растворљивости битно зависи од тачности експери-
менталних вредности за растворљивост које су коришћене за тренирање модела. У овом раду 
проучаван је значај примене експерименталних података добијених под стандардизованим, 
униформним условима за тренирање модела за предвиђање растворљивости. Коришћена су 
три сета података – испитивани сет 1 који је добијен одабиром експерименталних вредности 
за растворљивост под одређеним критеријумима из различитих литературних извора (n = 319), 
затим испитивани сет 2 који је добијен заменом 28 вредности за растворљивост из испити-
ваног сета 1 вредностима за растворљивост добијеним стандардизованом експерименталном 
методом у једној лабораторији (n = 319) и испитивани сет 3 који је добијен додатком још 56 
компонената у испитивани сет 2, за које су вредности растворљивисти такође одређене под 
стандардизованим условима у истој лабораторији (n = 375). Затим је примењена хеуристичка 
метода за селекцију најзначајнијих дескриптора, коришћењем једнопараметарских и више-
параметарских анализа. Постављене су корелације између најзначајнијих дескриптора и рас-
творљивости коришћењем мултилинеарне регресионе анализе за сва три испитивана сета по-
датака. Уочена је значајна разлика између једначина које су добијене коришћењем различи-
тих сетова података, што указује на то да је након увођења нових експерименталних 
података неопходно додатно оптимизовати постојеће моделе. Показано је да коришћење 
униформних експерименталних података условљава побољшање коефицијената корелације. 
Ови резултати говоре у прилог све заступљенијем ставу да је за побољшање поузданости 
предвиђања растворљивости потребно користити сетове података великог броја различитих 
једињења чија је растворљивост мерена под стандардизованим условима. 
(Примљено 9. августа, ревидирано 7. октобра 2009) 
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